| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |